212 related articles for article (PubMed ID: 28538692)
1. Exploring Anti-Prion Glyco-Based and Aromatic Scaffolds: A Chemical Strategy for the Quality of Life.
Blázquez-Sánchez MT; de Matos AM; Rauter AP
Molecules; 2017 May; 22(6):. PubMed ID: 28538692
[TBL] [Abstract][Full Text] [Related]
2. Soluble Prion Protein Binds Isolated Low Molecular Weight Amyloid-β Oligomers Causing Cytotoxicity Inhibition.
Williams TL; Choi JK; Surewicz K; Surewicz WK
ACS Chem Neurosci; 2015 Dec; 6(12):1972-80. PubMed ID: 26466138
[TBL] [Abstract][Full Text] [Related]
3. High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease.
Dohler F; Sepulveda-Falla D; Krasemann S; Altmeppen H; Schlüter H; Hildebrand D; Zerr I; Matschke J; Glatzel M
Brain; 2014 Mar; 137(Pt 3):873-86. PubMed ID: 24519981
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
[TBL] [Abstract][Full Text] [Related]
5. Distinct prion-like strains of amyloid beta implicated in phenotypic diversity of Alzheimer's disease.
Cohen M; Appleby B; Safar JG
Prion; 2016; 10(1):9-17. PubMed ID: 26809345
[TBL] [Abstract][Full Text] [Related]
6. Synthetic prions and other human neurodegenerative proteinopathies.
Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
[TBL] [Abstract][Full Text] [Related]
7. Phthalocyanines as Molecular Scaffolds to Block Disease-Associated Protein Aggregation.
Valiente-Gabioud AA; Miotto MC; Chesta ME; Lombardo V; Binolfi A; Fernández CO
Acc Chem Res; 2016 May; 49(5):801-8. PubMed ID: 27136297
[TBL] [Abstract][Full Text] [Related]
8. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates.
Soto C; Estrada L; Castilla J
Trends Biochem Sci; 2006 Mar; 31(3):150-5. PubMed ID: 16473510
[TBL] [Abstract][Full Text] [Related]
9. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
Savelieff MG; DeToma AS; Derrick JS; Lim MH
Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
[TBL] [Abstract][Full Text] [Related]
10. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
Matsuzaki K
Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
[TBL] [Abstract][Full Text] [Related]
11. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
Costanzo M; Zurzolo C
Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
[TBL] [Abstract][Full Text] [Related]
12. Modulation of prion polymerization and toxicity by rationally designed peptidomimetics.
Srivastava A; Sharma S; Sadanandan S; Gupta S; Singh J; Gupta S; Haridas V; Kundu B
Biochem J; 2017 Jan; 474(1):123-147. PubMed ID: 27803245
[TBL] [Abstract][Full Text] [Related]
13. High-Pressure Response of Amyloid Folds.
Torrent J; Martin D; Igel-Egalon A; Béringue V; Rezaei H
Viruses; 2019 Feb; 11(3):. PubMed ID: 30823361
[TBL] [Abstract][Full Text] [Related]
14. Aggregation of liposomes induced by the toxic peptides Alzheimer's Abetas, human amylin and prion (106-126): facilitation by membrane-bound GM1 ganglioside.
Kurganov B; Doh M; Arispe N
Peptides; 2004 Feb; 25(2):217-32. PubMed ID: 15063003
[TBL] [Abstract][Full Text] [Related]
15. A diversity of assembly mechanisms of a generic amyloid fold.
Eichner T; Radford SE
Mol Cell; 2011 Jul; 43(1):8-18. PubMed ID: 21726806
[TBL] [Abstract][Full Text] [Related]
16. Dissection of conformational conversion events during prion amyloid fibril formation using hydrogen exchange and mass spectrometry.
Singh J; Udgaonkar JB
J Mol Biol; 2013 Sep; 425(18):3510-21. PubMed ID: 23811055
[TBL] [Abstract][Full Text] [Related]
17. Pressure-temperature folding landscape in proteins involved in neurodegenerative diseases and cancer.
Cordeiro Y; Foguel D; Silva JL
Biophys Chem; 2013 Dec; 183():9-18. PubMed ID: 23849959
[TBL] [Abstract][Full Text] [Related]
18. Protein misfolding and prion diseases.
Cohen FE
J Mol Biol; 1999 Oct; 293(2):313-20. PubMed ID: 10550211
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
20. Structure of amyloid oligomers and their mechanisms of toxicities: Targeting amyloid oligomers using novel therapeutic approaches.
Salahuddin P; Fatima MT; Abdelhameed AS; Nusrat S; Khan RH
Eur J Med Chem; 2016 May; 114():41-58. PubMed ID: 26974374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
